As the COVID-19 pandemic continues to impact the world, healthcare providers have been at the forefront of the fight against the virus. Understanding the prevalence of COVID-19 antibodies among their staff is critical in ensuring their safety and the safety of the residents that they care for.
PremaLabs’ Chief Scientific Officer, Gary McLean, Professor Emeritus at London Metropolitan University and Honorary Senior Research Fellow at Imperial College London and his team will utilise its state-of-the-art testing capabilities to screen the staff at Cornerstone for the presence of COVID-19 antibodies. The results of these tests will be used to gain insight into the prevalence of the virus among healthcare workers and help identify potential areas for enhanced infection control practices.
“We are excited to welcome the PremaLabs team to our services and to be collaborating with them on this important initiative,” said Johann van Zyl, Cornerstone CEO. “By testing our staff for COVID-19 antibodies, we can gain a better understanding of the virus. We look forward to the valuable insights that this agreement will provide.”
“We are honoured to be working with Cornerstone Healthcare on this study” said PremaLabs CEO, Adam Martin. “Our advanced, portable testing services will enable us to provide Cornerstone with accurate data on the prevalence of COVID-19 antibodies among their staff, which will be crucial in implementing effective measures to keep their residents and employees safe.”
The collaboration between Cornerstone Healthcare and PremaLabs is a significant stride forward in the ongoing battle against COVID-19. Through this joint effort to gain a deeper understanding of the virus, these two organisations are at the forefront of safeguarding the health and welfare of both health and social care workers and their vulnerable residents. Cornerstone who cares for people with challenging behaviours associated with complex neurological and mental health needs, employs over 350 people across its three services – South Africa Lodge and Kitnocks House in Hampshire and Marula Lodge in Surrey.
PremaLabs Diagnostics is a global medical device company offering advanced and comprehensive Point of Care (POC) diagnostic solutions. This technology used in the care home environment can aid early and quick diagnosis of various conditions such as anaemia, cardiovascular diseases and diabetes. For more information visit their website at www.premalabs.uk.